• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Executive Officer Forman Michael C. sold $3,816,431 worth of shares (195,139 units at $19.56) (SEC Form 4)

    8/19/24 6:30:51 PM ET
    $FSK
    Investment Managers
    Finance
    Get the next $FSK alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Forman Michael C.

    (Last) (First) (Middle)
    C/O FS KKR CAPITAL CORP.
    201 ROUSE BOULEVARD

    (Street)
    PHILADELPHIA PA 19112

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    FS KKR Capital Corp [ FSK ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Executive Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    08/15/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 08/15/2024 S 180,704 D $19.5575 0 I FSH Seed Capital Vehicle I LLC(1)
    Common Stock 08/15/2024 S 14,435 D $19.5575 10,090.508 I Franklin Square Holdings, L.P.(2)
    Common Stock 124,551 I MCFDA SCV LLC(3)
    Common Stock 5,488 I Trust(4)
    Common Stock 8,649.023(5)(6) I Spouse
    Common Stock 6,884.782(5) I 401(k)
    Common Stock 14,221(5) I IRA
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. FSH Seed Capital Vehicle I LLC is a wholly-owned special purpose financing subsidiary of Franklin Square Holdings, L.P. The reporting person disclaims beneficial ownership of any shares held by FSH Seed Capital Vehicle I LLC that exceed his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the report shares for purposes of Section 16 or for any other purpose.
    2. The reporting person disclaims beneficial ownership of any shares held by Franklin Square Holdings, L.P. that exceed his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.
    3. MCFDA SCV LLC is a wholly-owned special purpose financing vehicle of which The 2011 Forman Investment Trust is a member. The reporting person disclaims beneficial ownership of any shares held by The 2011 Forman Investment Trust and MCFDA SCV LLC that exceed his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or any other purpose.
    4. The reporting person is a member of The 2011 Forman Investment Trust. The reporting person disclaims beneficial ownership of any shares held by The 2011 Forman Investment Trust that exceed his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or any other purpose.
    5. Includes shares received through stock distributions and shares received on account of reinvested distributions.
    6. Includes shares previously held in UGMA accounts for the reporting person's children that were previously reported as being held By Trust FBO Minor Children. The shares are now held jointly in individual accounts with the reporting person's spouse and the non-minor children.
    /s/ Stephen S. Sypherd, Attorney-in-Fact 08/19/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $FSK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FSK

    DatePrice TargetRatingAnalyst
    5/13/2025$19.00Neutral
    B. Riley Securities
    3/17/2025$21.00 → $19.00Equal Weight → Underweight
    Wells Fargo
    12/11/2024$21.50Buy → Neutral
    B. Riley Securities
    12/2/2024$21.00Overweight → Equal Weight
    Wells Fargo
    5/29/2024$19.00 → $21.00Equal Weight → Overweight
    Wells Fargo
    2/28/2024$20.00Outperform → Market Perform
    Hovde Group
    2/27/2024$21.50 → $19.50Buy → Neutral
    Compass Point
    7/28/2023$21.00Buy
    B. Riley Securities
    More analyst ratings